Adults aged 18-70 years old with metabolic risk metabolic syndrome coaching personalized lifestyle modification lifestyle medicine
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. adults aged 18-70 years old 2. meet at least one of the International Diabetes Federation (IDF) criteria for metabolic syndrome including 2.1 Central obesity (waist circumference 90 cm or higher in men and 80 cm or higher in women in Asian population) 2.2 Elevated triglycerides 150 milligrams per deciliter of blood (mg/dL) or greater (drug treatment for elevated triglycerides is an alternate indicator) 2.3 Reduced high-density lipoprotein cholesterol (HDL) less than 40 mg/dL in men or less than 50 mg/dL in women (drug treatment for reduced HDL-C is an alternate indicator) 2.4 Elevated fasting plasma glucose of l00 mg/dL or greater (drug treatment of elevated glucose is an alternate indicator) 2.5 Blood pressure values of systolic 130 mmHg or higher and/or diastolic 85 mmHg or higher (antihypertensive drug treatment in a patient with a history of hypertension is an alternate indicator)
Exclusion criteria
Exclusion criteria: 1. Having a health condition that prohibits exercise, such as being recently diagnosed with ischemic heart disease or having had a stroke within the past month, having excessively low or high blood pressure, or experiencing uncontrolled arrhythmia or a recent heart attack. 2. Unable to be monitored or tracked for a period of 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body mass index at 6 and 12 months Body mass index,Waist circumference at 6 and 12 months Waist circumference,Waist-to-hip ratio; WHR at 6 and 12 months Waist-to-hip ratio; WHR,Muscle strength at 6 and 12 months Sit to stand, Push-up,Cardiorespiratory fitness test at 6 and 12 months 6 Minute walk test; 6MWT,Flexibility at 6 and 12 months YMCA, V-sit-and-reach,Balance at 6 and 12 months Single leg balance test,stress at 6 and 12 months ST-5,Depression at 6 and 12 months 9Q, 8Q,Blood biomarkers for metabolic disease at 6 and 12 months Fasting blood sugar, HBA1c, Low-density lipoprotein, High-density lipoprotein, Total cholesterol, Triglyceride | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse event at 6 and 12 months clinical assessment | — |
Countries
Thailand
Contacts
Faculty of Medicine, Chiang Mai University